Syros Pharmaceuticals (NASDAQ:SYRS) Rating Increased to Hold at StockNews.com
Syros Pharmaceuticals (NASDAQ:SYRS – Get Free Report) was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Thursday. Syros Pharmaceuticals Price Performance NASDAQ SYRS opened at $5.35 on Thursday. The stock has a market capitalization of $112.72 million, a P/E ratio […]
More Stories
Primoris Services Co. (NASDAQ:PRIM) Given Average Rating of “Buy” by Analysts
Primoris Services Co. (NASDAQ:PRIM – Get Free Report) has received a consensus rating of “Buy” from the six research firms...
Analysts Set Texas Instruments Incorporated (NASDAQ:TXN) PT at $210.05
Texas Instruments Incorporated (NASDAQ:TXN – Get Free Report) has been given an average recommendation of “Hold” by the twenty-three brokerages...
HealthEquity, Inc. (NASDAQ:HQY) Receives Average Recommendation of “Moderate Buy” from Analysts
HealthEquity, Inc. (NASDAQ:HQY – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the fourteen brokerages...
Prime Medicine, Inc. (NYSE:PRME) Receives $12.67 Average PT from Brokerages
Prime Medicine, Inc. (NYSE:PRME – Get Free Report) has been given a consensus recommendation of “Buy” by the eleven ratings...
Fund L.P. Forager Sells 597 Shares of Regional Management Corp. (NYSE:RM) Stock
Regional Management Corp. (NYSE:RM – Get Free Report) major shareholder Fund L.P. Forager sold 597 shares of the stock in...
Fund L.P. Forager Sells 597 Shares of Regional Management Corp. (NYSE:RM) Stock
Regional Management Corp. (NYSE:RM – Get Free Report) major shareholder Fund L.P. Forager sold 597 shares of the stock in...